1.

Ensor, Mark, et al. Safety and Efficacy of D-Tagatose in Glycemic Control.

Journal of Endocrinology, Diabetes & Obesity. 2015;3(1):1065.

 

A Journal of Clinical Research on

“Safety and Efficacy of D-Tagatose in Glycemic Control” was issued by the

Department of Pharmaceutical Sciences, University of Kentucky,

USA in 2015.

 

Clinical Trial :

Is D-tagatose effective in controlling the glycemic index ?

(patients are not on any medication for diabetes)

 

Results :

(i)   D-tagatose controls the glycemic index.

(ii)  Unlike many other diabetes drugs, the longer a patient is on D-tagatose therapy,

      the better the efficacy.

 

 

 

 

2.

Lee, Kyungsun, et al. Glycemic Index of Sucrose with D-Xylose (XF) in Humans.

Current Topics in Nutraceutical Research. 2013;11(1/2):35-40.

 

A Journal of Clinical Research on

“Glycemic Index of Sucrose with D-Xylose (XF) in Humans”was jointly issued by

TS Corporation, Korea & Department of Applied Bioscience, CHA University,

Korea in 2013.

 

Clinical Trial :

Can D-xylose inhibit sucrase activity, block the absorption of sucrose, and control the glycemic index?

 

Results :

(i)    GI tests were conducted 2 hours after the consumption of D-xylose and sucrose. The postprandial

       glycemic indices of those who consumed D-xylose + sucrose were significantly lower than the

       GI of those who consumed sucrose only.

(ii)   It is clinically verified that D-xylose can inhibit sucrase activity, slowing down the breakdown and

       absorption of sucrose.

(iii)  D-xylose is more effective in obese individuals.